|
End-of-day quote
Korea S.E.
28/08/2026
|
5-day change | 1st Jan Change | ||
| 7,410.00 KRW | -1.59% |
|
-1.85% | -54.54% |
| 05-18 | TegoScience Inc. agreed to acquire 95.77% stake in PNP Pharm Co., Ltd. for KRW 3.7 billion. | CI |
| 26/05/25 | TegoScience Inc. announced that it has received KRW 27 billion in funding | CI |
| Market Cap | 59.33B 43.05M 37.09M 34.78M 31.75M 59.81M 4.11B 60M 413M 161M 2.08B 162M 158M 6.89B | P/E 2024 |
29.9x | P/E 2025 | -18.6x |
|---|---|---|---|---|---|
| Enterprise Value | 24.04B 17.45M 15.03M 14.09M 12.87M 24.24M 1.67B 24.32M 167M 65.25M 842M 65.5M 64.07M 2.79B | EV / Sales 2024 |
11x | EV / Sales 2025 | 16x |
| Free-Float |
51.46% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -1.59% | ||
| 1 week | -1.85% | ||
| Current month | +17.99% | ||
| 1 month | +32.32% | ||
| 3 months | -24.39% | ||
| 6 months | -43.00% | ||
| Current year | -54.54% |
| 1 week | 7,000 |  | 7,900 |
| 1 month | 5,840 | | 8,970 |
| Current year | 5,230 | | 16,500 |
| 1 year | 5,230 | | 19,370 |
| 3 years | 5,230 | | 26,100 |
| 5 years | 5,230 | | 28,700 |
| 10 years | 5,230 | | 73,500 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sae-Wha Jeon
CEO | Chief Executive Officer | 60 | 19/03/2001 |
Han-Kyu Jang
PRN | Corporate Officer/Principal | 53 | - |
Sung-In Chung
AUD | Comptroller/Controller/Auditor | 65 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sae-Wha Jeon
BRD | Director/Board Member | 60 | 19/03/2001 |
Jae-Wook Jeon
BRD | Director/Board Member | 63 | 19/03/2001 |
Han-Kyu Jang
BRD | Director/Board Member | 53 | 30/04/2001 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.59% | -1.85% | -59.77% | -22.41% | 43.05M | |
| -1.67% | -4.78% | +36.76% | -4.34% | 79.3B | |
| -0.90% | +2.39% | -19.06% | -35.50% | 59.21B | |
| -3.35% | -4.92% | +472.81% | +18.97% | 55.09B | |
| -6.78% | -4.19% | -3.45% | +28.35% | 49.86B | |
| -2.43% | -2.35% | +8.33% | +160.40% | 47.9B | |
| -1.35% | +0.79% | +65.25% | -18.47% | 32.28B | |
| -2.64% | -2.69% | +46.99% | +92.55% | 25.21B | |
| -0.09% | +4.98% | +11.00% | +199.86% | 23.87B | |
| -0.34% | +1.35% | +62.33% | +122.21% | 16.89B | |
| Average | -2.11% | -1.06% | +62.12% | +54.16% | 38.97B | |
| Weighted average by Cap. | -2.42% | -2.05% | +83.83% | +41.75% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 6.76B 4.9M 4.23M 3.96M 3.62M 6.81M 469M 6.84M 47.01M 18.34M 237M 18.41M 18.01M 785M | 5.94B 4.31M 3.71M 3.48M 3.18M 5.99M 412M 6.01M 41.32M 16.12M 208M 16.18M 15.83M 690M |
| Net income | 3.35B 2.43M 2.09M 1.96M 1.79M 3.38M 232M 3.39M 23.3M 9.09M 117M 9.12M 8.93M 389M | -7.01B -5.09M -4.38M -4.11M -3.75M -7.07M -486M -7.09M -48.77M -19.03M -245M -19.1M -18.69M -814M |
| Net Debt | -25.58B -18.56M -15.99M -15M -13.69M -25.79M -1.77B -25.87M -178M -69.42M -895M -69.69M -68.17M -2.97B | -35.28B -25.6M -22.06M -20.68M -18.88M -35.57M -2.45B -35.68M -245M -95.75M -1.24B -96.12M -94.03M -4.1B |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/08/26 | ₩7,410.00 | -1.59% | 7,036 |
| 27/08/26 | ₩7,530.00 | -0.66% | 1,498 |
| 26/08/26 | ₩7,580.00 | -0.26% | 912 |
| 25/08/26 | ₩7,600.00 | +2.70% | 1,394 |
| 24/08/26 | ₩7,400.00 | -1.99% | 4,316 |
- Stock Market
- Stocks
- A191420 Stock
Select your edition
All financial news and data tailored to specific country editions
